UTI Healthcare Fund Regular Plan Growth is a Sector - Healthcare mutual fund scheme from UTI Asset Management Co Ltd. The fund was launched on 28 June 1999 and is managed by Kamal Gada. As of 15 October 2026, the fund has an AUM of ₹1,429.84 Cr and its latest NAV is ₹320.76. The fund has a Very High Risk risk rating.
The fund allows minimum SIP of ₹500 and lumpsum investment starting from ₹5,000.
The fund primarily invests in Healthcare and its top holdings include Sun Pharmaceuticals Industries Ltd, Divi's Laboratories Ltd, Dr Reddy's Laboratories Ltd, Ajanta Pharma Ltd, and Gland Pharma Ltd. The fund has delivered 10.6% returns over the last 1 year, 20.2% annualised returns over 3 years, 13.3% annualised returns over 5 years, and 14.7% annualised returns since inception.
UTI Healthcare Fund Regular Plan Growth may be suitable for investors looking for Sector - Healthcare and who are comfortable with Very High Risk risk.






